Z-1308-2023 Class II Ongoing

Recalled by Quidel Corporation — Athens, OH

FDA device recall Z-1308-2023 was initiated by Quidel Corporation on Feb 1, 2023 and is designated Class II. Reason for recall: Kits with affected microtiter plates have the potential to produce low OD values, causing the run to fail, per the Validation requirements of the Package Insert. The recall status is ongoing. Affected quantity: 771 units.

Recall details

Product Type
Devices
Report Date
Apr 5, 2023
Initiation Date
Feb 1, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
771 units

Product description

MicroVue C1-Inhibitor Plus EIA for measuring the amount of functional C1-lnhibitor protein in human plasma or serum, Catalog Number A037, Containing Coated Strips, REF: 4634, with an ID number of 2200 or above

Reason for recall

Kits with affected microtiter plates have the potential to produce low OD values, causing the run to fail, per the Validation requirements of the Package Insert.

Distribution pattern

not yet available

Code information

UDI: 30014613335580; Lot Number: 213783

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1308-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1308-2023. Report a data issue: hello@regdatalab.com.